http://www.InteretTherapeutique.org/grossesse/ New studies included in the knowledge base of medication and pregnancy en studies http://www.txrating.org/grossesse/viewMA.aspx?exposition=25Kalyanasundaram et al. Impact of valproate discontinuation on seizure control in women of reproductive age. Epileptic Disord 2026; :http://www.txrating.org/grossesse/viewMA.aspx?exposition=25Duchemin et al. Identification of major congenital malformations based on healthcare databases in France: A proof-of-concept study using the epi-meres nationwide mother-child register. Br J Clin Pharmacol 2026; :http://www.txrating.org/grossesse/viewMA.aspx?exposition=25Umer et al. Gabapentin and Opioid Coexposure During Pregnancy and Adverse Perinatal Outcomes: A Population-Based Study, 2020-2024. Am J Perinatol 2026; :http://www.txrating.org/grossesse/viewMA.aspx?exposition=25Lopes et al. Pregnancy outcomes following Eslicarbazepine acetate exposure in women with epilepsy: A global safety database analysis from clinical development to 16 years of post-marketing experience. Seizure 2026; 140:62-68http://www.txrating.org/grossesse/viewMA.aspx?exposition=25Honybun et al. Neurocognitive Outcomes of In Utero Exposure to Antiseizure Medication: An Australian Cohort Study. Neurology 2026; 107:e218122http://www.txrating.org/grossesse/viewMA.aspx?exposition=25Beau et al. Gabapentin and Pregabalin Use in First Trimester of Pregnancy and Risk of Specific Congenital Anomalies: An IMI ConcePTION European Case-Malformed Control Study. Drug Saf 2026; :http://www.txrating.org/grossesse/viewMA.aspx?exposition=25Moore et al. Anti-seizure medication in pregnancy and pregnancy, baby, and child outcomes: a population-based cohort study. Nature Portfolio (Preprint) 2025. https://doi.org/10.21203/rs.3.rs-6576771/v1http://www.txrating.org/grossesse/viewMA.aspx?exposition=25Karayagmurlu et al. Maternal epilepsy and prenatal antiepileptic drug exposure: Relationships with neurodevelopmental outcomes in preschool-aged children. Appl Neuropsychol Child 2026; :1-9http://www.txrating.org/grossesse/viewMA.aspx?exposition=25Li et al. Development of cerebral lateralization in children exposed to fetal antiseizure medications: A prospective cohort study at age 6?years. Epilepsia 2026; 67:2412-2424http://www.txrating.org/grossesse/viewMA.aspx?exposition=25Stjerna et al. Does in utero exposure to antiseizure medications affect the trajectory of cognitive development from 2 to 6?years of age? Brain Dev 2026; 48:104487